To investigate the role of LIN7A in DAC treatment in t(8;21) AML, we knocked down LIN7A in Kasumi-1 and SKNO-1 cells using targeted shRNAs before treatment with DAC (Fig. 3m). The gene discussed is LIN7A; the disease is acute myeloid leukemia.